Literature DB >> 42551

Acid excretion in young and adult Wistar Kyoto and spontaneously hypertensive rats.

M Belledonne, J M Preuss, H G Preuss.   

Abstract

Wistar Kyoto rats (WKy), the most widely accepted control for SH rats, show an inability to excrete acid appropriately when compared to another normotensive strain, SD. Coupled with the fact than KWy also develops 'sodium-sensitive' hypertension, this makes them a more complex control than realized. At very young ages (less than 10-week-old), neither SH nor WKy show any deficiency in acid excretion.

Entities:  

Mesh:

Year:  1979        PMID: 42551     DOI: 10.1007/bf01953213

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  7 in total

1.  Acid excretion in spontaneously hypertensive rats.

Authors:  H G Preuss; L L Vertuno; O Vavatsi-Manos; H S Washington
Journal:  Proc Soc Exp Biol Med       Date:  1976-11

2.  Enhanced salt toxicity in the spontaneously hypertensive rat.

Authors:  J A Barsanti; H R Pillsbury; E D Freis
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

3.  Renal handling of sodium in Kyoto-Okamoto rats: a micropuncture study.

Authors:  A Vandewalle; N Farman; J P Bonvalet
Journal:  Am J Physiol       Date:  1978-11

4.  Exaggerated natriuresis in the conscious spontaneously hypertensive rat.

Authors:  L R Willis; P W McCallum; J T Higgins
Journal:  J Lab Clin Med       Date:  1976-02

5.  Blunted norepinephrine natriuresis in the isolated spontaneously hypertensive rat kidney.

Authors:  T H Steele; J L Underwood
Journal:  Am J Physiol       Date:  1978-11

6.  EFFECTS OF CHRONIC EXCESS SALT INGESTION. ROLE OF GENETIC FACTORS IN BOTH DOCA-SALT AND RENAL HYPERTENSION.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  J Exp Med       Date:  1963-10-01       Impact factor: 14.307

7.  Effects of chronia excess salt ingestion. Evidence that genetic factors play an important role in susceptibility to experimental hypertension.

Authors:  L K DAHL; M HEINE; L TASSINARI
Journal:  J Exp Med       Date:  1962-06-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.